Jacquelyn Sumer
Oficial de Cumplimiento en CULLINAN THERAPEUTICS, INC. .
Fortuna: 2 M $ al 30/04/2024
Cargos activos de Jacquelyn Sumer
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Oficial de Cumplimiento | 15/08/2022 | - |
| Consejero General | 15/08/2022 | - | |
| Secretario Corporativo | 15/08/2022 | - |
Historial de carrera de Jacquelyn Sumer
Antiguos cargos conocidos de Jacquelyn Sumer.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CELGENE | Director/Miembro de la Junta | 01/05/2017 | 01/07/2018 |
| Corporate Officer/Principal | 01/05/2017 | 01/07/2018 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
| GENOCEA BIOSCIENCES, INC. | Oficial de Cumplimiento | 01/02/2021 | - |
| Consejero General | 01/02/2021 | - |
Formación de Jacquelyn Sumer.
| Duke University School of Law | Graduate Degree |
| Bucknell University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Compliance Officer | 2 |
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Jacquelyn Sumer
- Experiencia
